ELTX
Pharmaceuticals, Biotechnology & Life Sciences
CROWD: AMBER
Institutional ownership is building here (3 rising quarters). Not yet crowded, but the quiet phase is ending.
Active holders
13
of 47 total, index funds excluded
Streak
3q
consecutive rising quarters
The crowd, 2016 to now
active holders per quarter
2023Mar 2026
Holdings as of Mar 31, 2026, filed by May 16, 2026. Counts for the newest quarter keep settling for a few weeks as amendments land.
The tide
funds in (up) vs out (down)
Top holders
by reported value · $28M held
| Fund | Value | Note |
| Knoll Capital Management, L… |
$7M |
|
| VANGUARD CAPITAL MANAGEMENT… |
$6M |
|
| Balyasny Asset Management L… |
$3M |
|
| GEODE CAPITAL MANAGEMENT, L… |
$1M |
|
| RENAISSANCE TECHNOLOGIES LLC |
$1M |
|
| MILLENNIUM MANAGEMENT LLC |
$992K |
|
| MARSHALL WACE, LLP |
$797K |
|
| SUSQUEHANNA INTERNATIONAL G… |
$757K |
|
| VANGUARD FIDUCIARY TRUST CO |
$740K |
|
| NORTHERN TRUST CORP |
$639K |
|
Tourists vs true believers
every holder a dot · right = bigger bet in their own book, up = patient money
Hover any dot for the fund and its bet size. Patience is measured from each filer's actual quarter-to-quarter turnover across our whole database.